Course ObjectiveThe aim is to obtain experience in scientific research including the
design and execution of experiments and to critically interpret and
reflect on the experimental results. The project will be conducted
within the field of molecular and computational toxicology, in one of
the following settings:
- University or Academic hospital
- Research institute
The internship can be performed either within the Netherlands or abroad.
Course ContentThe specific content of the project depends on the available projects
and timing of the internship, but roughly deals with one of the
following areas of research:
- Biomolecular Simulation & Modeling (dr. Daan Geerke): computational
methods are developed to characterize the interaction between compounds
with different proteins and to predict their mode of binding and action.
In close collaboration with the experimental colleagues within the
division, a special focus is possible on predicting unwanted binding to
drug-safety related proteins and/or the formation of metabolites by
drug-metabolizing or biocatalytically active enzymes. The binding
affinity and -selectivity of compounds and metabolites are calculated
using efficient and accurate computational methods, and research on and
development of improved biomolecular models or force fields is possible
- Phase I and II metabolism (dr. Jan Commandeur): Research is focused on
the role of drug metabolizing enzymes, such as cytochromes P450,
glutathione transferases, sulfotransferases, and others in the
bioactivation and bioinactivation of (toxic) drugs or other chemicals
and the development of novel in vitro models for liver and kidney
- In vitro cell toxicology (Prof. dr. Paul Jennings): Utilisation of
cultured human cells, including primary cells, renal cell lines, hepatic
cell lines and induced human pluripotent stem cells for investigating
mechanisms of toxicity. Assays employed include, cytotoxicity assays,
stress assays, differentiation markers, mitochondrial injury (Seahorse
bioanalyser), barrier function, impedance (xCELLigence), fluorescent
reporter assays, transcriptomics and biokinetics.
Attention will be paid to setting up new research/experiments, using
state-of-the-art experimental or computational techniques, and data
analysis and interpretation.
Teaching MethodsLiterature review, formulating a research question, conducting
experiments and/or simulation, documentation (e.g. labjournal, adherence
to protocols, appropriate meta tagging and documentation of workflows),
data analysis, reporting on results in group meetings, a written thesis
and final presentation within the research group.
Method of AssessmentAcademic attitude, execution, oral presentation, and written thesis
Entry RequirementsEntry requirements with respect to attained courses and number of
credits apply. See the Education and Examination regulations and the
internship manual Drug Discovery & Safety. For questions, consult the
internship coordinator well in advance (email@example.com).
LiteratureStarting literature will be provided by the supervisor. The first 1-2
weeks of the traineeship will be spent on literature reading and
preparation for the project.
Target AudienceResearch variant of all specializations of the master Drug Discovery &
Safety (DDSA, CMCT, DDTF, DD&S, BCCA)
Additional InformationThe length of a minor internship ranges from 18 to 36 EC (3-6 months)
and can be (partly) incorporated within the optional part of the master
program. For traineeships abroad and in companies a length of at least
30 EC is recommended. Consult the master coordinator of your track well
in advance to discuss your personal education plan. See the “Master Drug
Discovery & Safety Internship manual” for more information (rules,
regulations, tips, etc.) on the internship process. This manual can be
found on the canvas community “Master Drug Discovery & Safety”.
Custom Course RegistrationThe number of internal (VU) internship positions is limited. Candidates are selected based on their motivation (in form of a motivation letter), and previous experience (outlined in CV). Please refer to the canvas site “Master Drug Discovery & Safety” for more information regarding this application procedure. Be aware that for most external positions a selection procedure applies as well. Before the start of the project an internship agreement, which includes a non-disclosure agreement has to be signed by all involved parties and the project proposal has to be approved by the VU supervisor. See the “Master Drug Discovery & Safety Internship manual” for more information on the rules and regulation regarding internships. Contact either Paul Jennings, Jan Commandeur or Daan Geerke for specifics on the availability of projects. If after reading the manual you still have questions regarding the process related to internships, admission, approval, etc., please contact the internship coordinator via firstname.lastname@example.org.
|Period||Ac. Year (sept)|
|Language of Tuition||English|
|Faculty||Faculty of Science|
|Course Coordinator||dr. D.J. Scholten|
|Examiner||dr. D.J. Scholten|
You cannot register for this course yourself; your faculty's education office carries out registration
This course is also available as: